About: Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2000 (uk) article scientifique publié en juillet 2000 (fr) im Juli 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2000 (ast) scientific article published on 01 July 2000 (en)
publication date	wds:Q63363342-6C886CE0-FD20-4E6E-A234-9D7328A291F3 wds:Q63363342-DC491D15-4481-43CE-8050-2C8F82E82B72
publication date	2000-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q63363342-76E7821A-DEB3-44A5-A5F2-4F8C79C5033F
language of work or name	English
author name string	wds:Q63363342-0096D2D2-FBE1-4A11-B4CE-401B386AC1C2 wds:Q63363342-368C2E6B-BBE5-46E2-A96D-FA073087E43E wds:Q63363342-3F67EA17-E528-4DE0-BB97-B48ED829092C wds:Q63363342-64E71695-4808-462B-A6B1-A3264273CF19 wds:Q63363342-6549FB21-9D2C-4829-9437-67FF419B95A3 wds:Q63363342-6BD264B8-E7E0-467C-BE23-C140817543D1 wds:Q63363342-6F33D843-5655-4D28-97A6-993994B9E53D wds:Q63363342-80F2A349-6C70-4683-84AE-B1A7C9716EFF wds:Q63363342-83BA41D1-BD2C-447E-87E3-348E6BC80E51 wds:Q63363342-83E30400-BB98-4746-848B-06636F866EE6 wds:Q63363342-BE20F8A0-9F6E-4F95-8365-CD3A5A1E8F8F wds:Q63363342-EC38328F-9CA7-422B-BDA9-F6C581EC28B4 wds:Q63363342-F942881A-0C9E-472D-B742-17FA60319B95
author name string	Ko Okumura Takeda K Okumura K Kazuyoshi Takeda Kawamura T Naito T Abo T Toru Abo Toshihiko Kawamura Yasser Osman Osman Y Tetsuya Naito Luc Van Kaer
rdfs:label	Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide (en) Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide (nl)
skos:prefLabel	Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide (en) Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide (nl)
name	Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide (en) Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide (nl)
author	wds:Q63363342-E8BBD57E-82B5-4C88-B28C-90CF417A1BC4
author	Luc Van Kaer
title	wds:Q63363342-DFFEE9DD-3F8B-49E4-BDC4-33C0D83BB81B wds:Q63363342-F0FABD7D-5915-4728-9DF5-304862A3472D
title	Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide (en) Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide (en)
page(s)	wds:Q63363342-3868515E-4989-4B52-B439-E63BDBDEA59C
page(s)	1919-1928
instance of	wds:Q63363342-99B08B47-3878-4EC0-8144-B4931F64B1E2
instance of	scholarly article
PubMed ID	wds:Q63363342-59601D9E-9E5D-43DB-A484-0AC57050606F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10940881
PubMed ID	10940881
published in	wds:Q63363342-FC173094-B274-4B40-8341-9AA634875F75
published in	European Journal of Immunology
issue	wds:Q63363342-8FE33097-8808-41DD-89DD-4BD0D62506AE
volume	wds:Q63363342-42F271B0-0304-4E21-A7DA-E5A481C2954B
issue	7
volume	30
DOI	wds:Q63363342-06CEAFEE-C052-4A39-B3AF-87EA1EFA9DB9
DOI	http://dx.doi.org/10.1002/1521-4141(200007)30:7%3C1919::AID-IMMU1919%3E3.0.CO;2-3
DOI	10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3
skos:altLabel	Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide (en) Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide (nl)
is owl:sameAs of	Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q63363342
is cites work of	Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation Total enantioselective synthesis and in vivo biological evaluation of a novel fluorescent BODIPY alpha-galactosylceramide. Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide The role of innate immunity in HBV infection Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB. NKT cells: facts, functions and fallacies. Immunotherapy with ligands of natural killer T cells NKT cells: potential targets for autoimmune disease therapy? The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes NK cells and NKT cells in innate defense against viral infections Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis Activation of NKT cells protects mice from tuberculosis. Invariant natural killer T cells: bridging innate and adaptive immunity alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles Liver autoimmunity triggered by microbial activation of natural killer T cells Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo To be or not to be NKT: natural killer T cells in the liver. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases AIM inhibits apoptosis of T cells and NKT cells in Corynebacterium-induced granuloma formation in mice Age-related bias in function of natural killer T cells and granulocytes after stress: reciprocal association of steroid hormones and sympathetic nerves CD1d function is regulated by microsomal triglyceride transfer protein. NKT cells: what's in a name? Therapeutic effect of repeated natural killer T cell stimulation in mouse cholangitis complicated by colitis PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software